⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetone SCHEMBL1320683 | 0.96 | LMNA (0.50) | — | |
| Acetone SCHEMBL2391921 | 0.96 | LMNA (0.50) | — | |
| Acetone SCHEMBL292856 | 0.95 | LMNA (0.60) | — | |
| Acetone SCHEMBL6859028 | 0.95 | LMNA (0.60) | — | |
| Acetone SCHEMBL1831044 | 0.95 | LMNA (0.60) | — | |
| Acetone SCHEMBL9324675 | 0.95 | LMNA (0.60) | — | |
| Acetone SCHEMBL9217023 | 0.95 | LMNA (0.60) | — | |
| Acetone SCHEMBL6859386 | 0.95 | LMNA (0.60) | — | |
| Acetone SCHEMBL1244296 | 0.95 | LMNA (0.60) | — | |
| Acetone SCHEMBL6859109 | 0.95 | LMNA (0.60) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 345 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113125627-B | Detection method for effective components of traditional Chinese medicine composition for treating nephropathy | 云南雷允上理想药业有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-113125627-A | Detection method for effective components of traditional Chinese medicine composition for treating nephropathy | 云南雷允上理想药业有限公司 | 2021-07-16 | — | — | CN | claimed |
| CN-108484711-B | A method of preparing gypenoside LI | 海门市彼维知识产权服务有限公司 | 2019-04-05 | — | — | CN | claimed |
| CN-108276466-B | A method of preparing gypenoside LVI | 娄志春 | 2019-03-08 | — | — | CN | claimed |
| CN-108484712-B | A method of preparing damulin A | 娄志春 | 2019-03-08 | — | — | CN | claimed |
| CN-108484713-B | A method of preparing gypenoside L | 娄志春 | 2019-03-05 | — | — | CN | claimed |
| CN-108410940-B | A kind of method that microbe transformation method prepares damulin B | 娄志春 | 2019-03-05 | — | — | CN | claimed |
| CN-108440631-B | A method of preparing gypenoside XLVI | 绍兴市逸晨医疗科技有限公司 | 2018-12-21 | — | — | CN | claimed |
| CN-108179169-B | A kind of method that microbe transformation method prepares damulin A | 江苏天芳健康科技有限公司 | 2018-11-23 | — | — | CN | claimed |
| CN-108178778-B | A method of preparing damulin B | 邳州高新区生物医药研究院有限公司 | 2018-11-20 | — | — | CN | claimed |
| CN-108484713-A | A method of preparing gypenoside L | 娄志春 | 2018-09-04 | — | — | CN | claimed |
| CN-108484711-A | A method of preparing gypenoside LI | 娄志春 | 2018-09-04 | — | — | CN | claimed |
| CN-108484712-A | A method of preparing damulin A | 娄志春 | 2018-09-04 | — | — | CN | claimed |
| CN-108459129-A | A kind of method of quality control of Tetrandra and Poria Decoction composition | 华润三九医药股份有限公司 | 2018-08-28 | — | — | CN | claimed |
| CN-108410940-A | A kind of method that microbe transformation method prepares damulin B | 娄志春 | 2018-08-17 | — | — | CN | claimed |
| CN-108179169-A | A kind of method that microbe transformation method prepares damulin A | 娄志春 | 2018-06-19 | — | — | CN | claimed |
| CN-108178778-A | A kind of method for preparing damulin B | 娄志春 | 2018-06-19 | — | — | CN | claimed |
| CN-105980390-B | A kind of crystal form of disulfate of jak kinase inhibitor and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2017-07-07 | — | — | CN | claimed |
| CN-106589043-A | Application of aryl substitute acryl triterpenoids to preparation of anticomplement drugs | 复旦大学 | 2017-04-26 | — | — | CN | claimed |
| CN-117347514-A | Thin-layer chromatography identification method for canna plant | 广西天缘绿生物科技有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-112972438-B | Lignan compound from radix paeoniae rubra, and preparation method and application thereof | 中国医学科学院药物研究所 | 2023-05-05 | — | — | CN | disclosed |
| CN-113125627-B | Detection method for effective components of traditional Chinese medicine composition for treating nephropathy | 云南雷允上理想药业有限公司 | 2022-10-18 | — | — | CN | disclosed |
| CN-113125627-A | Detection method for effective components of traditional Chinese medicine composition for treating nephropathy | 云南雷允上理想药业有限公司 | 2021-07-16 | — | — | CN | disclosed |
| CN-112972438-A | Lignan compounds derived from radix paeoniae rubra as well as preparation method and application thereof | 中国医学科学院药物研究所 | 2021-06-18 | — | — | CN | disclosed |
| CN-107513089-B | Novel cytidine derivative dimer and application thereof | 常州方圆制药有限公司 | 2021-04-02 | — | — | CN | disclosed |
| CN-107652339-B | Novel cytidine derivative and application thereof | 常州方圆制药有限公司 | 2021-04-02 | — | — | CN | disclosed |
| CN-107501369-B | Preparation method and application of cytidine derivative | 常州方圆制药有限公司 | 2020-05-15 | — | — | CN | disclosed |
| US-10508092-B2 | Synthesis of novel analogs of diptoindonesin G, compounds formed thereby, and pharmaceutical compositions containing them | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2019-12-17 | — | — | US | disclosed |
| CN-106146583-B | Novel cytidine derivative and use thereof | 常州方圆制药有限公司 | 2019-11-08 | — | — | CN | disclosed |
| CN-106866652-B | Jamaicin 12- bit derivant with insulin-sensitizing activity and preparation method thereof | 四川大学 | 2019-04-23 | — | — | CN | disclosed |
| CN-108484711-B | A method of preparing gypenoside LI | 海门市彼维知识产权服务有限公司 | 2019-04-05 | — | — | CN | disclosed |
| CN-108484712-B | A method of preparing damulin A | 娄志春 | 2019-03-08 | — | — | CN | disclosed |
| CN-108276466-B | A method of preparing gypenoside LVI | 娄志春 | 2019-03-08 | — | — | CN | disclosed |
| CN-108410940-B | A kind of method that microbe transformation method prepares damulin B | 娄志春 | 2019-03-05 | — | — | CN | disclosed |
| CN-108484713-B | A method of preparing gypenoside L | 娄志春 | 2019-03-05 | — | — | CN | disclosed |
| CN-106146584-B | Novel cytidine derivative dimer and use thereof | 常州方圆制药有限公司 | 2019-03-01 | — | — | CN | disclosed |
| CN-106589043-B | Aryl substituted acryl triterpene compound is preparing the purposes in anticomplement medicament | 复旦大学 | 2019-02-26 | — | — | CN | disclosed |
| CN-108440631-B | A method of preparing gypenoside XLVI | 绍兴市逸晨医疗科技有限公司 | 2018-12-21 | — | — | CN | disclosed |
| CN-108178778-B | A method of preparing damulin B | 邳州高新区生物医药研究院有限公司 | 2018-11-20 | — | — | CN | disclosed |
| CN-108484713-A | A method of preparing gypenoside L | 娄志春 | 2018-09-04 | — | — | CN | disclosed |
| CN-108484712-A | A method of preparing damulin A | 娄志春 | 2018-09-04 | — | — | CN | disclosed |
| CN-108484711-A | A method of preparing gypenoside LI | 娄志春 | 2018-09-04 | — | — | CN | disclosed |
| CN-108459129-A | A kind of method of quality control of Tetrandra and Poria Decoction composition | 华润三九医药股份有限公司 | 2018-08-28 | — | — | CN | disclosed |
| CN-108440631-A | A method of preparing gypenoside XLVI | 娄志春 | 2018-08-24 | — | — | CN | disclosed |
| CN-108276466-A | A method of preparing gypenoside LVI | 娄志春 | 2018-07-13 | — | — | CN | disclosed |
| CN-108178778-A | A kind of method for preparing damulin B | 娄志春 | 2018-06-19 | — | — | CN | disclosed |
| EP-2495234-B1 | AROMATIC SULFONIUM SALT COMPOUND | ADEKA CORP (JP) | 2018-06-06 | — | — | EP | disclosed |
| US-20180065945-A1 | SYNTHESIS OF NOVEL ANALOGS OF DIPTOINDONESIN G, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2018-03-08 | — | — | US | disclosed |
| CN-105980390-B | A kind of crystal form of disulfate of jak kinase inhibitor and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2017-07-07 | — | — | CN | disclosed |
| CN-106589043-A | Application of aryl substitute acryl triterpenoids to preparation of anticomplement drugs | 复旦大学 | 2017-04-26 | — | — | CN | disclosed |
| EP-2896612-A1 | Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors | Wyeth Holdings LLC (US) | 2015-07-22 | — | — | EP | disclosed |
| CN-104706718-A | Three-ingredient Chinese gentian flower tablets and preparation method thereof | SICHUAN YUTUO TIBETAN MEDICINE INDUSTRY CO LTD | 2015-06-17 | — | — | CN | disclosed |
| CN-102590434-B | Detection method of preparation comprising eight Chinese herbal medicines for calming | TIBETAN CHEEZHENG TIBETAN MEDICINE CO LTD | 2014-08-13 | — | — | CN | disclosed |
| CN-102520113-B | Detection method for fifteen Rupeng preparation | TIBETAN CHEEZHENG TIBETAN MEDICINE CO LTD | 2014-05-07 | — | — | CN | disclosed |
| EP-2253620-B1 | SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS | WYETH HOLDINGS LLC (US) | 2014-03-12 | — | — | EP | disclosed |
| CN-103570747-A | Preparation technology for cefbuperazone sodium | ANHUI YOUCARE KAIYUE PHARMACEUTICAL CO LTD | 2014-02-12 | — | — | CN | disclosed |
| US-20140034623-A1 | SWITCHABLE SPECIAL EFFECT SUBSTANCES | BASF SE (DE) | 2014-02-06 | — | — | US | disclosed |
| US-8586745-B2 | Switchable special effect substances | BASF SE (DE) | 2013-11-19 | — | — | US | disclosed |
| EP-2431370-B1 | Monoacylated 1,2-diaminocycloalkanes | DAIICHI SANKYO CO LTD (JP) | 2013-06-19 | — | — | EP | disclosed |
| US-8304406-B2 | Compounds for treating pulmonary hypertension | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2012-11-06 | — | — | US | disclosed |
| EP-1577301-B1 | Antithrombotic diaminocyclohexane derivatives | DAIICHI SANKYO CO LTD (JP) | 2012-09-12 | — | — | EP | disclosed |
| EP-2495234-A1 | AROMATIC SULFONIUM SALT COMPOUND | Adeka Corporation (JP) | 2012-09-05 | — | — | EP | disclosed |
| US-8236795-B2 | IL-12 modulatory compounds | SYNTA PHARMACEUTICALS CORP. (US) | 2012-08-07 | — | — | US | disclosed |
| EP-1270557-B1 | ETHYLENEDIAMINE DERIVATIVES | DAIICHI SANKYO CO LTD (JP) | 2012-07-25 | — | — | EP | disclosed |
| CN-102590434-A | Detection method of preparation comprising eight Chinese herbal medicines for calming | TIBETAN CHEEZHENG TIBETAN MEDICINE CO LTD | 2012-07-18 | — | — | CN | disclosed |
| CN-102520113-A | Detection method for fifteen Rupeng preparation | TIBETAN CHEEZHENG TIBETAN MEDICINE CO LTD | 2012-06-27 | — | — | CN | disclosed |
| US-20120130117-A1 | AROMATIC SULFONIUM SALT COMPOUND | ADEKA CORPORATION (JP) | 2012-05-24 | — | — | US | disclosed |
| CN-101363819-B | Quality control method for yuye qinghuo capsule | GUANGXI BOKE PHARMACEUTICAL CO LTD | 2012-04-18 | — | — | CN | disclosed |
| EP-2431370-A1 | Monoacylated 1,2-diaminocycloalkanes | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2012-03-21 | — | — | EP | disclosed |
| US-20110312990-A1 | Diamine Derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2011-12-22 | — | — | US | disclosed |
| US-20110263597-A1 | SUBSTITUTED PYRIDINES AND PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY | BAYER HEALTHCARE LLC (US) | 2011-10-27 | — | — | US | disclosed |
| EP-2343290-A1 | Diamine derivatives as factor X inhibitors | Daiichi Sankyo Company, Limited (JP) | 2011-07-13 | — | — | EP | disclosed |
| US-7977333-B2 | Hyperpermeability; diabetic retinopathy, ischemic retinal-vein occlusion, prematurity, age-related macular degeneration | BAYER HEALTHCARE LLC (US) | 2011-07-12 | — | — | US | disclosed |
| US-RE42376-E1 | Substituted 3-cyanoquinolines | WYETH HOLDINGS CORPORATION (US) | 2011-05-17 | — | — | US | disclosed |
| US-7935824-B2 | Ethylenediamine derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2011-05-03 | — | — | US | disclosed |
| US-7919487-B2 | Heteroaryl compounds | SYNTA PHARMACEUTICALS CORPORATION (US) | 2011-04-05 | — | — | US | disclosed |
| US-20110077266-A1 | Diamine Derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2011-03-31 | — | — | US | disclosed |
| US-20110060113-A1 | SWITCHABLE SPECIAL EFFECT SUBSTANCES | BASF SE (DE) | 2011-03-10 | — | — | US | disclosed |
| EP-2253620-A1 | Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors | Wyeth Holdings Corporation (US) | 2010-11-24 | — | — | EP | disclosed |
| US-20100256132-A1 | IL-12 MODULATORY COMPOUNDS | SYNTA PHARMACEUTICALS CORPORATION (US) | 2010-10-07 | — | — | US | disclosed |
| US-20100120722-A1 | HETEROCYCLIC COMPOUNDS FOR PREVENTING AND TREATING DISORDERS ASSOCIATED WITH EXCESSIVE BONE LOSS | SYNTA PHARMACEUTICALS CORP. (US) | 2010-05-13 | — | — | US | disclosed |
| US-20100113452-A1 | COMPOUNDS FOR TREATING PULMONARY HYPERTENSION | BAYER HEALTHCARE AG (DE) | 2010-05-06 | — | — | US | disclosed |
| US-20100099660-A1 | METHOD FOR TREATING THROMBOSIS OR EMBOLISM AND RELATED DISEASES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2010-04-22 | — | — | US | disclosed |
| US-20100093785-A1 | DIAMINE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2010-04-15 | — | — | US | disclosed |
| US-7696202-B2 | IL-12 modulatory compounds | SYNTA PHARMACEUTICALS CORP. (US) | 2010-04-13 | — | — | US | disclosed |
| US-20090281074-A1 | DRUG COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING THROMBOSIS OR EMBOLISM | DAIICHI PHARMACEUTICAL CO., LTD (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20090270446-A1 | DIAMINE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2009-10-29 | — | — | US | disclosed |
| EP-1754475-B1 | Use of C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases | IDUN PHARMACEUTICALS INC (US) | 2009-09-16 | — | — | EP | disclosed |
| US-20090227789-A1 | ETHYLENEDIAMINE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2009-09-10 | — | — | US | disclosed |
| US-7576135-B2 | Diamine derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2009-08-18 | — | — | US | disclosed |
| EP-1228063-B1 | SUBSTITUTED PYRIDINES AND PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY | BAYER CORP (US) | 2009-02-11 | — | — | EP | disclosed |
| CN-101363819-A | Quality control method for yuye qinghuo capsule | GUANGXI BOKE PHARMACEUTICAL CO (CN) | 2009-02-11 | — | — | CN | disclosed |
| EP-2010173-A1 | COMPOUNDS FOR TREATING PULMONARY HYPERTENSION | Bayer HealthCare AG (DE) | 2009-01-07 | — | — | EP | disclosed |
| EP-1212339-B1 | 2'-O-ACETAMIDO MODIFIED MONOMERS AND OLIGOMERS | ISIS PHARMACEUTICALS INC (US) | 2008-12-31 | — | — | EP | disclosed |
| CN-100422173-C | Substituted pyridines and pyridazines with angiogenesis inhibiting activity | BAYER PHARMACEUTICALS CORP (US) | 2008-10-01 | — | — | CN | disclosed |
| CN-100422172-C | Substituted pyridines and pyridazines with angiogenesis inhibiting activity | BAYER PHARMACEUTICALS CORP (US) | 2008-10-01 | — | — | CN | disclosed |
| US-7410990-B2 | Heterocyclic compounds | SYNTA PHARMACEUTICALS CORP. (US) | 2008-08-12 | — | — | US | disclosed |
| EP-1950201-A1 | Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors | Wyeth Holdings Corporation (US) | 2008-07-30 | — | — | EP | disclosed |
| US-7365205-B2 | Cyclic diamine derivatives useful as agents for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism; inhibit activated blood coagulation factor X | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2008-04-29 | — | — | US | disclosed |
| CN-100374435-C | Substituted pyridazines having angiogenesis inhibiting activity | BAYER CORP (US) | 2008-03-12 | — | — | CN | disclosed |
| US-7342014-B2 | Diamine derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2008-03-11 | — | — | US | disclosed |
| US-20080058297-A1 | Heterocyclic Compounds For Preventing And Treating Disorders Associated With Excessive Bone Loss | SYNTA PHARMACEUTICALS CORP. (US) | 2008-03-06 | — | — | US | disclosed |
| US-20080015215-A1 | DIAMINE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2008-01-17 | — | — | US | disclosed |
| WO-2007118602-A1 | COMPOUNDS FOR TREATING PULMONARY HYPERTENSION | BAYER HEALTHCARE AG (DE) | 2007-10-25 | — | — | WO | disclosed |
| EP-1819341-A2 | IL-12 MODULATORY COMPOUNDS | Synta Pharmaceuticals Corporation (US) | 2007-08-22 | — | — | EP | disclosed |
| US-7192968-B2 | Ethylenediamine derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2007-03-20 | — | — | US | disclosed |
| US-7183260-B2 | C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases | IDUN PHARMACEUTICALS, INC. (US) | 2007-02-27 | — | — | US | disclosed |
| EP-1754475-A1 | Use of C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases | Idun Pharmaceuticals, Inc. (US) | 2007-02-21 | — | — | EP | disclosed |
| EP-1575900-A4 | N-METHYL AMINO ACIDS | UBIQUITOUS TECHNOLOGIES PTY LT (AU) | 2007-02-21 | — | — | EP | disclosed |
| US-20070027151-A1 | Heterocyclic compounds | SYNTA PHARMACEUTICALS CORP. (US) | 2007-02-01 | — | — | US | disclosed |
| US-7157430-B2 | (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases | IDUN PHARMACEUTICALS, INC. (US) | 2007-01-02 | — | — | US | disclosed |
| US-20060252837-A1 | Cyclic diamine derivatives useful as agents for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism; inhibit activated blood coagulation factor X | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-11-09 | — | — | US | disclosed |
| CN-1283656-C | C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases | IDUN PHARMACEUTICALS INC (US) | 2006-11-08 | — | — | CN | disclosed |
| US-7122665-B2 | Heterocyclic compounds | SYNTA PHARMACEUTICALS CORP. (US) | 2006-10-17 | — | — | US | disclosed |
| US-20060223996-A1 | IL-12 modulatory compounds | SYNTA PHARMACEUTICALS CORP. (US) | 2006-10-05 | — | — | US | disclosed |
| US-7071195-B2 | Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2006-07-04 | — | — | US | disclosed |
| US-20060122156-A1 | Heteroaryl compounds | SYNTA PHARMACEUTICALS CORP. (US) | 2006-06-08 | — | — | US | disclosed |
| US-7053056-B2 | C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases | IDUN PHARMACEUTICALS, INC. (US) | 2006-05-30 | — | — | US | disclosed |
| US-20060111553-A1 | Novel thrombin inhibitors, the preparation and use thereof | ABBOTT GMBH & CO. KG (DE) | 2006-05-25 | — | — | US | disclosed |
| WO-2006053227-A2 | IL-12 MODULATORY COMPOUNDS | SYNTA PHARMACEUTICALS CORP. (US) | 2006-05-18 | — | — | WO | disclosed |
| WO-2006053109-A1 | HETEROARYL COMPOUNDS | SYNTA PHARMACEUTICALS CORP. (US) | 2006-05-18 | — | — | WO | disclosed |
| CN-1769282-A | Substituted pyridines and pyridazines with angiogenesis inhibiting activity | BAYER PHARMACEUTICALS CORP (US) | 2006-05-10 | — | — | CN | disclosed |
| CN-1769283-A | Substituted pyridines and pyridazines with angiogenesis inhibiting activity | BAYER PHARMACEUTICALS CORP (US) | 2006-05-10 | — | — | CN | disclosed |
| EP-1647279-A2 | Inhibition of apoptosis using interleukin-1beta-converting enzyme (ICE)/CED-3 family inhibitors | Idun Pharmaceuticals, Inc. (US) | 2006-04-19 | — | — | EP | disclosed |
| US-20060052388-A1 | Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders | DAX SCOTT L | 2006-03-09 | — | — | US | disclosed |
| EP-1626725-A2 | HETEROCYCLIC COMPOUNDS FOR PREVENTING AND TREATING DISORDERS ASSOCIATED WITH EXCESSIVE BONE LOSS | Synta Pharmaceuticals Corporation (US) | 2006-02-22 | — | — | EP | disclosed |
| EP-0929311-B8 | INHIBITION OF APOPTOSIS USING INTERLEUKIN-1 beta-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS | IDUN PHARMACEUTICALS INC (US) | 2006-02-01 | — | — | EP | disclosed |
| US-20060004009-A1 | Ethylenediamine derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-01-05 | — | — | US | disclosed |
| EP-0929311-B1 | INHIBITION OF APOPTOSIS USING INTERLEUKIN-1 beta-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS | IDUN PHARMACEUTICALS INC (US) | 2005-11-23 | — | — | EP | disclosed |
| US-20050245565-A1 | Diamine derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2005-11-03 | — | — | US | disclosed |
| US-20050245432-A1 | N-methyl amino acids | UBIQUITOUS TECHNOLOGIES PTY. LTD. (AU) | 2005-11-03 | — | — | US | disclosed |
| EP-1577301-A1 | DIAMINE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2005-09-21 | — | — | EP | disclosed |
| EP-1575900-A1 | N-METHYL AMINO ACIDS | UBIQUITOUS TECHNOLOGIES PTY LTD (AU) | 2005-09-21 | — | — | EP | disclosed |
| CN-1213044-C | Amine and amide derivatives as ligands of the neuropeptide YY5 receptor for the treatment of obesity and other diseases | ORTHO MCNEIL PHARM INC (US) | 2005-08-03 | — | — | CN | disclosed |
| US-6903101-B1 | Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity | BAYER PHARMACEUTICALS CORPORATION (US) | 2005-06-07 | — | — | US | disclosed |
| US-20050119486-A1 | Diamine derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2005-06-02 | — | — | US | disclosed |
| US-6900319-B2 | Thrombin inhibitors | ABBOTT GMBH & CO. KG (DE) | 2005-05-31 | — | — | US | disclosed |
| US-6897230-B2 | Bicyclo[3/1/0] hexane containing oxazolidinone antibiotics and derivatives thereof | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2005-05-24 | — | — | US | disclosed |
| US-20050020504-A1 | C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases | IDUN PHARMACEUTICALS, INC. (US) | 2005-01-27 | — | — | US | disclosed |
| US-20050020645-A1 | Diamine derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2005-01-27 | — | — | US | disclosed |
| WO-2005000404-A2 | HETEROCYCLIC COMPOUNDS FOR PREVENTING AND TREATING DISORDERS ASSOCIATED WITH EXCESSIVE BONE LOSS | SYNTA PHARMACEUTICALS, CORP. (US) | 2005-01-06 | — | — | WO | disclosed |
| EP-1493742-A1 | Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders | Ortho-Mcneil Pharmaceutical, Inc. (US) | 2005-01-05 | — | — | EP | disclosed |
| EP-0869958-B1 | NOVEL INDOLE-2,3-DIONE-3-OXIME DERIVATIVES | NEUROSEARCH AS (DK) | 2004-12-29 | — | — | EP | disclosed |
| EP-1066037-B1 | USE OF INDOLE-2,3-DIONE-3-OXIME DERIVATIVES AS AMPA ANTAGONISTS | NEUROSEARCH AS (DK) | 2004-12-29 | — | — | EP | disclosed |
| US-20040259804-A1 | (Substituted)Acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases | IDUN PHARMACEUTICALS, INC. | 2004-12-23 | — | — | US | disclosed |
| EP-0972775-B1 | PYRROLOINDOLE DERIVATIVES AND INTERMEDIATES IN PRODUCING THE SAME | KYORIN SEIYAKU KK (JP) | 2004-12-08 | — | — | EP | disclosed |
| EP-1480999-A2 | (SUBSTITUTED)ACYL DIPEPTIDYL INHIBITORS OF THE ICE/CED-3 FAMILY OF CYSTEINE PROTEASES | Idun Pharmaceuticals (US) | 2004-12-01 | — | — | EP | disclosed |
| EP-1311300-A4 | RADIOLIGAND AND BINDING ASSAY | MERCK & CO INC (US) | 2004-11-03 | — | — | EP | disclosed |
| CN-1535958-A | Alpha-substituted pyrimidine. thioalkyl and alkyl ether compound | �������Ŷ���Լ��������˾ | 2004-10-13 | — | — | CN | disclosed |
| US-20040198725-A1 | A bi-heterocyclic compound e.g 3-methoxyphenyl)-{6-Morpholin-4-yl-2-[2-(pyridin-2-yloxy)-ethoxy]-9H-purin-8-yl}-amine or other derivatives useful for treating an interleukin-12 overproduction-related disorder such as rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis or diabetes | SYNTA PHARMACEUTICALS CORP. | 2004-10-07 | — | — | US | disclosed |
| EP-0824524-B1 | ALPHA-SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETHER COMPOUNDS AS INHIBITORS OF VIRAL REVERSE TRANSCRIPTASE | UPJOHN CO (US) | 2004-09-08 | — | — | EP | disclosed |
| CN-1525978-A | C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases | 伊邓药品公司 | 2004-09-01 | — | — | CN | disclosed |
| EP-1449835-A2 | Alpha-substituted pyrimidine-thioalkyl and alkylether compounds | PHARMACIA & UPJOHN COMPANY (US) | 2004-08-25 | — | — | EP | disclosed |
| EP-1443935-A2 | TREATMENT OF INFECTIOUS DISEASE USING INTERLEUKIN-1 BETA CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS | Idun Pharmaceuticals, Inc. (US) | 2004-08-11 | — | — | EP | disclosed |
| CN-1159289-C | C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cystenine proteases | ������˹ҩƷ��˾ | 2004-07-28 | — | — | CN | disclosed |
| US-6759384-B1 | LOW MOLECULAR WEIGHT ANTICOAGULANTS WITHOUT SIDE EFFECTS; DERIVATIVES OF AT LEAST PROLINE, LEUCINE AND ARGININE SEQUENCE | AVENTIS PHARMACEUTICALS INC. | 2004-07-06 | — | — | US | disclosed |
| US-20040122063-A1 | Ethylenediamine derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2004-06-24 | — | — | US | disclosed |
| EP-1023316-A4 | METHODS AND COMPOSITIONS FOR LIPIDIZATION OF HYDROPHILIC MOLECULES | UNIV SOUTHERN CALIFORNIA (US) | 2004-06-09 | — | — | EP | disclosed |
| US-6747023-B1 | INHIBITORS FOR ACTIVATED COAGULATION FACTOR X, COAGULATION SUPPRESSORS | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2004-06-08 | — | — | US | disclosed |
| CN-1152022-C | Alpha-substituted pyrimidine-thioalkyl and alkylether compounds | �������Ŷ���Լ��������˾ | 2004-06-02 | — | — | CN | disclosed |
| US-20040092740-A1 | Substituted pyridines and pyridazines with angiogenesis inhibiting activity | BAYER PHARMACEUTICALS CORPORATION | 2004-05-13 | — | — | US | disclosed |
| EP-1415992-A1 | DIAMINE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2004-05-06 | — | — | EP | disclosed |
| US-20040082611-A1 | Anticoagulants; brain disorders; respiratory system disorders; side effect reduction | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2004-04-29 | — | — | US | disclosed |
| EP-1208096-B1 | SUBSTITUTED PYRIDAZINES AND FUSED PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY | BAYER AG (US) | 2004-04-28 | — | — | EP | disclosed |
| EP-1405852-A1 | DIAMINE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2004-04-07 | — | — | EP | disclosed |
| US-20040058850-A1 | Using caspase inhibitor; antiinflammatory agents | IDUN PHARMACEUTICALS, INC. | 2004-03-25 | — | — | US | disclosed |
| EP-0758341-B1 | FACTOR Xa INHIBITORS | AVENTIS PHARMA INC (US) | 2004-03-24 | — | — | EP | disclosed |
| EP-1118616-B1 | Process for the production of 5'-nor-anhydrovinblastine ditartrate from plants of genus catharanthus | ERIOCHEM SA (AR) | 2004-03-24 | — | — | EP | disclosed |
| US-RE38460-E1 | Huperzine A derivatives, their preparation and their use | SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES (CN) | 2004-03-09 | — | — | US | disclosed |
| WO-2004014882-A2 | PROTEASOME INHIBITORS : PEPTIDE DERIVATIVES HAVING C-TERMINAL HETEROARYL GROUPS | AXYS PHARMACEUTICALS (US) | 2004-02-19 | — | — | WO | disclosed |
| US-6693096-B2 | SUPPRESSING PROTEASE ACTIVITY | IDUN PHARMACEUTICALS, INC. | 2004-02-17 | — | — | US | disclosed |
| US-6693111-B1 | 1H-PYRROLO(3,2-H)ISOQUINOLINE DERIVATIVES; EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS | NEUROSEARCH A/S (DK) | 2004-02-17 | — | — | US | disclosed |
| US-6689883-B1 | Substituted pyridines and pyridazines with angiogenesis inhibiting activity | BAYER PHARMACEUTICALS CORPORATION | 2004-02-10 | — | — | US | disclosed |
| EP-1384725-A2 | Factor Xa inhibitors | Aventis Pharmaceuticals, Inc. (US) | 2004-01-28 | — | — | EP | disclosed |
| WO-2004007427-A1 | N-METHYL AMINO ACIDS | UBIQUITOUS TECHNOLOGIES PTY LTD (AU) | 2004-01-22 | — | — | WO | disclosed |
| US-20030232788-A1 | (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases | IDUN PHARMACEUTICALS, INC. | 2003-12-18 | — | — | US | disclosed |
| EP-1117659-B1 | SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS | WYETH CORP (US) | 2003-12-03 | — | — | EP | disclosed |
| EP-1351975-A2 | C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/CED-3 FAMILY OF CYSTEINE PROTEASES | Idun Pharmaceuticals, Inc. (US) | 2003-10-15 | — | — | EP | disclosed |
| US-20030186842-A1 | Contacting a cell population with an inhibiting effective amount of a reagent that suppresses the protease activity of at least one member of the interleukin-1beta- converting enzyme (ICE)/CED-3 family | IDUN PHARMACEUTICALS, INC. (US) | 2003-10-02 | — | — | US | disclosed |
| WO-2003072528-A2 | (SUBSTITUTED)ACYL DIPEPTIDYL INHIBITORS OF THE ICE/CED-3 FAMILY OF CYSTEINE PROTEASES | IDUN PHARMACEUTICALS, INC. (US) | 2003-09-04 | — | — | WO | disclosed |
| US-6610683-B2 | Programmed cell death; expansion of hematopoietic cells, for prolonging viability of an organ for transplantation, and maintaining viability of cell lines used in bioproduction | IDUN PHARMACEUTICALS, INC. | 2003-08-26 | — | — | US | disclosed |
| EP-0680962-B1 | Heterocyclic compounds | ASTRAZENECA AB (SE) | 2003-08-20 | — | — | EP | disclosed |
| US-RE38200-E1 | Capable of antagonizing effect of excitatory amino acids, such as glutamate | NEUROSEARCH A/S (DK) | 2003-07-22 | — | — | US | disclosed |
| US-20030125367-A1 | Bicyclo[3,1,0]hexane containing oxazolidinone antibioytics and derivatives thereof | KYORIN PHARMACEUTICAL CO., LTD. | 2003-07-03 | — | — | US | disclosed |
| US-6579569-B2 | Uses multi-slot coating apparatus to apply multiple liquid layers to moving substrate; high speed, for photographic film and paper products | EASTMAN KODAK COMPANY | 2003-06-17 | — | — | US | disclosed |
| CN-1420879-A | Substituted pyridines and pyridazines having angiogenesis inhibiting activity | BAYER AG (US) | 2003-05-28 | — | — | CN | disclosed |
| EP-1311300-A1 | RADIOLIGAND AND BINDING ASSAY | Merck & Co., Inc. (US) | 2003-05-21 | — | — | EP | disclosed |
| WO-2003032918-A2 | TREATMENT OF INFECTIOUS DISEASE USING INTERLEUKIN-1 BETA CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS | IDUN PHARMACEUTICALS, INC. (US) | 2003-04-24 | — | — | WO | disclosed |
| US-6544951-B2 | Antiinflammatory agents; autoimmune diseases, nervous system degradation | IDUN PHARMACEUTICALS, INC. | 2003-04-08 | — | — | US | disclosed |
| US-6534114-B2 | Uses multi-slot coating apparatus to apply multiple liquid layers to moving substrate; high speed, for photographic film and paper products | EASTMAN KODAK COMPANY | 2003-03-18 | — | — | US | disclosed |
| US-6531467-B2 | Inhibition of inflammation using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors | IDUN PHARMACEUTICALS, INC. | 2003-03-11 | — | — | US | disclosed |
| US-6528506-B2 | Viability of organs transplants | IDUN PHARMACEUTICALS, INC. | 2003-03-04 | — | — | US | disclosed |
| US-20030039661-A1 | Methods, compositions and kits for preserving antigenicity | IDUN PHARMACEUTICALS, INC. | 2003-02-27 | — | — | US | disclosed |
| US-20030004308-A1 | Novel thrombin inhibitors, the preparation and use thereof | BOHM HANS-JOACHIM (DE) | 2003-01-02 | — | — | US | disclosed |
| EP-1270557-A1 | ETHYLENEDIAMINE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2003-01-02 | — | — | EP | disclosed |
| CN-1382135-A | Amine and amide derivatives as ligands for neuropeptide YY5 receptor usefu in treatment of obesity and other disorders | ORTHO MCNEIL PHARM INC (US) | 2002-11-27 | — | — | CN | disclosed |
| US-20020169318-A1 | Novel thrombin inhibitors | ABBVIE DEUTSCHLAND GMBH & CO KG (DE) | 2002-11-14 | — | — | US | disclosed |
| CN-1378543-A | Substituted pyridazines and fused pyridazines having angiogenesis inhibiting activity | BAYER AG (US) | 2002-11-06 | — | — | CN | disclosed |
| CN-1093859-C | Novel indole-2,3-done-3-oxime derivatives | NEUROSEARCH AS (DK) | 2002-11-06 | — | — | CN | disclosed |
| US-20020160119-A1 | Coating method | EASTMAN KODAK COMPANY | 2002-10-31 | — | — | US | disclosed |
| US-20020160120-A1 | Coating method for modifying adhesion of thin films to substrates | EASTMAN KODAK COMPANY | 2002-10-31 | — | — | US | disclosed |
| US-20020147171-A1 | Inhibition of apoptosis using interleukin-1beta converting enzyme (ICE)/CED-3 family inhibitors | IDUN PHARMACEUTICALS, INC. (US) | 2002-10-10 | — | — | US | disclosed |
| EP-0604352-B1 | Aryl-substituted heterocyclic compounds | NEUROSEARCH AS (DK) | 2002-10-09 | — | — | EP | disclosed |
| EP-0906279-B1 | PYRROLE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2002-10-02 | — | — | EP | disclosed |
| US-6455671-B1 | COMPOUND FOR USE IN THE TREATMENT OF THROMBOSIS | ABBOTT LABORATORIES | 2002-09-24 | — | — | US | disclosed |
| EP-1212339-A4 | 2'-O-ACETAMIDO MODIFIED MONOMERS AND OLIGOMERS | ISIS PHARMACEUTICALS INC (US) | 2002-09-18 | — | — | EP | disclosed |
| US-20020128306-A1 | Programmed cell death; expansion of hematopoietic cells, for prolonging viability of an organ for transplantation, and maintaining viability of cell lines used in bioproduction | IDUN PHARMACEUTICALS, INC. | 2002-09-12 | — | — | US | disclosed |
| WO-2002070544-A2 | METHODS, COMPOSITIONS AND KITS FOR PRESERVING ANTIGENICITY | IDUN PHARMACEUTICALS, INC. (US) | 2002-09-12 | — | — | WO | disclosed |
| US-20020123522-A1 | Inhibition of inflammation using interleukin-1beta-converting enzyme (ICE)/CED-3 family inhibitors | IDUN PHARMACEUTICALS, INC. (US) | 2002-09-05 | — | — | US | disclosed |
| US-6444663-B2 | TREATMENT OF PATIENTS SUFFERING INFLAMMATORY, AUTOIMMUNE AND NEURODEGENERATIVE DISEASES, AND FOR THE PREVENTION OF ISCHEMIC INJURY. | IDUN PHARMACEUTICALS, INC. | 2002-09-03 | — | — | US | disclosed |
| US-6444817-B1 | ANTICOAGULANTS | ABBOTT LABORATORIES | 2002-09-03 | — | — | US | disclosed |
| US-20020115715-A1 | Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders | DAX SCOTT L (US) | 2002-08-22 | — | — | US | disclosed |
| EP-1228063-A2 | SUBSTITUTED PYRIDINES AND PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY | Bayer Corporation (US) | 2002-08-07 | — | — | EP | disclosed |
| WO-2002057298-A2 | C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/CED-3 FAMILY OF CYSTEINE PROTEASES | IDUN PHARMACEUTICALS, INC. (US) | 2002-07-25 | — | — | WO | disclosed |
| US-20020091089-A1 | (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases | KARANEWSKY DONALD S (US) | 2002-07-11 | — | — | US | disclosed |
| EP-1212339-A1 | 2'-O-ACETAMIDO MODIFIED MONOMERS AND OLIGOMERS | ISIS PHARMACEUTICALS, INC. (US) | 2002-06-12 | — | — | EP | disclosed |
| EP-1208096-A1 | SUBSTITUTED PYRIDAZINES AND FUSED PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY | Bayer Corporation (US) | 2002-05-29 | — | — | EP | disclosed |
| EP-1202986-A1 | AMINE AND AMIDE DERIVATIVES AS LIGANDS FOR THE NEUROPEPTIDE Y Y5 RECEPTOR USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS | Ortho-McNeil Pharmaceutical, Inc. (US) | 2002-05-08 | — | — | EP | disclosed |
| US-6380224-B1 | FOR THERAPY OF EATING DISORDERS, OBESITY, BULIMIA NERVOSA, DIABETES, MEMORY LOSS, EPILEPTIC SEIZURES, MIGRAINE, SLEEP DISTURBANCES, PAIN, SEXUAL/REPRODUCTIVE DISORDERS, DEPRESSION AND ANXIETY | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2002-04-30 | — | — | US | disclosed |
| US-20020042376-A1 | C-terminal modified oxamyl dipeptides as inhibitors of the ICE-ced-3 family of cysteine proteases | CONATUS PHARMACEUTICALS, INC. | 2002-04-11 | — | — | US | disclosed |
| EP-0874850-B1 | NOVEL TRICYCLIC COMPOUNDS FOR THE INHIBITION OF THE ICE/CED-3 PROTEASE FAMILY OF ENZYMES | IDUN PHARMACEUTICALS INC (US) | 2002-04-10 | — | — | EP | disclosed |
| US-20020028774-A1 | C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases | CONATUS PHARMACEUTICALS, INC. | 2002-03-07 | — | — | US | disclosed |
| US-20020016321-A1 | Novel tricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymes | KARANEWSKY DONALD S (US) | 2002-02-07 | — | — | US | disclosed |
| WO-2002005860-A1 | RADIOLIGAND AND BINDING ASSAY | MERCK & CO., INC. (US) | 2002-01-24 | — | — | WO | disclosed |
| US-20010044415-A1 | Inhibition of apoptosis using interleukin-1B-converting enzyme (ICE)/CED-3 family inhibitors | FRITZ LAWRENCE C (US) | 2001-11-22 | — | — | US | disclosed |
| US-6297258-B1 | USEFUL AS ANTINEOPLASTIC AGENTS AND IN THE TREATMENT OF POLYCYSTIC KIDNEY DISEASE. | AMERICAN CYANAMID COMPANY | 2001-10-02 | — | — | US | disclosed |
| CN-1313846-A | C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cystenine proteases | IDUN PHARMACEUTICALS INC (US) | 2001-09-19 | — | — | CN | disclosed |
| US-6288082-B1 | COMPOUNDS SUCH AS 6,7-DIETHOXY-4-(INDAN-5-YLAMINO) -QUINOLINE-3-CARBONITRILE USED AS ANTINEOPLASTIC AGENTS AND IN THE TREATMENT OF POLYCYCSTIC KIDNEY DISEASE | AMERICAN CYANAMID COMPANY | 2001-09-11 | — | — | US | disclosed |
| EP-0929311-A4 | INHIBITION OF APOPTOSIS USING INTERLEUKIN-1 beta-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS | IDUN PHARMACEUTICALS INC (US) | 2001-08-29 | — | — | EP | disclosed |
| EP-1123272-A1 | (SUBSTITUTED)ACYL DIPEPTIDYL INHIBITORS OF THE ICE/CED-3 FAMILY OF CYSTEINE PROTEASES | Idun Pharmaceuticals, Inc. (US) | 2001-08-16 | — | — | EP | disclosed |
| EP-1118616-A1 | Process for the production of 5'-nor-anhydrovinblastine ditartrate from plants of genus catharanthus | Eriochem, S.A. (AR) | 2001-07-25 | — | — | EP | disclosed |
| EP-1117659-A1 | SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS | American Cyanamid Company (US) | 2001-07-25 | — | — | EP | disclosed |
| US-6242422-B1 | (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases | IDUN PHARMACUETICALS, INC. | 2001-06-05 | — | — | US | disclosed |
| US-6239128-B1 | COMBATING DISEASES AND DISORDERS ASSOCIATED WITH OR MEDIATED BY THE RELEASE OF EXCITATORY AMINO ACIDS, ASSOCIATED WITH REDUCED BLOOD FLOW TO THE BRAIN AND OTHER CNS TISSUE, | NEUROSEARCH A/S (DK) | 2001-05-29 | — | — | US | disclosed |
| WO-2001023375-A2 | SUBSTITUTED PYRIDINES AND PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY | BAYER CORPORATION (US) | 2001-04-05 | — | — | WO | disclosed |
| US-6200969-B1 | CONTACTING CELLS WITH REAGENT WHICH SUPPRESSES PROTEASE ACTIVITY OF INTERLEUKIN-1.BETA.-CONVERTING ENZYME (ICE)/CED-3 FAMILY, INHIBITING APOPTOSIS IN CELL POPULATION TO EXPANDING OR INCREASING SURVIVAL OF CELL POPULATION | IDUN PHARMACEUTICALS, INC. | 2001-03-13 | — | — | US | disclosed |
| US-6197750-B1 | ENZYME INHIBITORS; ANTIINFLAMMATORY AGENTS | IDUN PHARMACEUTICALS, INC. | 2001-03-06 | — | — | US | disclosed |
| WO-2001014400-A1 | 2'-O-ACETAMIDO MODIFIED MONOMERS AND OLIGOMERS | ISIS PHARMACEUTICALS, INC. (US) | 2001-03-01 | — | — | WO | disclosed |
| WO-2001010859-A1 | SUBSTITUTED PYRIDAZINES AND FUSED PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY | BAYER CORPORATION (US) | 2001-02-15 | — | — | WO | disclosed |
| US-6187771-B1 | Tricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymes | IDUN PHARMACEUTICALS, INC. | 2001-02-13 | — | — | US | disclosed |
| WO-2001009120-A1 | AMINE AND AMIDE DERIVATIVES AS LIGANDS FOR THE NEUROPEPTIDE Y Y5 RECEPTOR USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2001-02-08 | — | — | WO | disclosed |
| EP-1066037-A1 | INDOLE-2,3-DIONE-3-OXIME DERIVATIVES FOR THERAPEUTIC USE | NEUROSEARCH A/S (DK) | 2001-01-10 | — | — | EP | disclosed |
| US-6136844-A | ANTIINFLAMMATORY AGENT; AUTOIMMUNE DISEASE | SYNTEX (U.S.A.) INC. (US) | 2000-10-24 | — | — | US | disclosed |
| US-6127402-A | AN INHIBITORS OF PROSTAGLANDIN G/H SYNTHASE AND ARE ANTI-INFLAMMATORY AND ANALGESIC AGENTS | SYNTEX (U.S.A.) INC. (US) | 2000-10-03 | — | — | US | disclosed |
| US-6124285-A | Indole-2,3-dione-3-oxime derivatives | NEUROSEARCH A/S (DK) | 2000-09-26 | — | — | US | disclosed |
| EP-0604355-B1 | Akyl Substituted heterocyclic compounds | NEUROSEARCH AS (DK) | 2000-08-09 | — | — | EP | disclosed |
| EP-1023316-A2 | METHODS AND COMPOSITIONS FOR LIPIDIZATION OF HYDROPHILIC MOLECULES | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2000-08-02 | — | — | EP | disclosed |
| US-6093692-A | FATTY ACID DERIVATIVES OF DISULFIDE-CONTAINING COMPOUNDS SUCH AS DISULFIDE-CONTAINING PEPTIDES OR PROTEINS) COMPRISING FATTY ACID-CONJUGATED PRODUCTS WITH A DISULFIDE LINKAGE; IMPROVING BIOAVAILABILITY OF PEPTIDES, PROTEINS | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2000-07-25 | — | — | US | disclosed |
| US-6080859-A | 1-CHLOROMETHYL, 3-((HETEROARYL OR ARYL)CARBONYL), 5-(HETEROCYCLE-AMINOCARBONYLOXY),7-TRIFLUOROMETHYL, 8-ALKOXYCARBONYL-1,2,3,6-TETRAHYDROPYRROLO(3,2-E)INDOLE OF GIVEN STRUCTURE; ANTITUMOR AND ANTIMICROBIAL ACTIVITY | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2000-06-27 | — | — | US | disclosed |
| WO-2000023421-A1 | (SUBSTITUTED)ACYL DIPEPTIDYL INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES | IDUN PHARMACEUTICALS, INC. (US) | 2000-04-27 | — | — | WO | disclosed |
| WO-2000018761-A1 | SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 2000-04-06 | — | — | WO | disclosed |
| US-6043248-A | VIRICIDES FOR TREATING AN INDIVIDUAL INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS | PHARMACIA & UPJOHN COMPANY (US) | 2000-03-28 | — | — | US | disclosed |
| US-6030972-A | 2- OR 5-AMINOMETHYL,2- OR 5-CYANOPYRIMIDINES AS INTERMEDIATES OF ANTICOAGULANTS IN EXTRACORPOREAL CIRCULATION (HEART-LUNG MACHINE, HEMODIALYSIS) | BASF AKTIENGESELLSCHAFT (DE) | 2000-02-29 | — | — | US | disclosed |
| EP-0972775-A1 | PYRROLOINDOLE DERIVATIVES AND INTERMEDIATES IN PRODUCING THE SAME | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2000-01-19 | — | — | EP | disclosed |
| EP-0781284-B1 | INDOLE-2,3-DIONE-3-OXIME DERIVATIVES, THEIR PREPARATION AND USE | NEUROSEARCH AS (DK) | 2000-01-12 | — | — | EP | disclosed |
| EP-0781285-B1 | FUSED INDOLE AND QUINOXALINE DERIVATIVES, THEIR PREPARATION AND USE AS GLUTAMATE ANTAGONISTS | NEUROSEARCH AS (DK) | 2000-01-12 | — | — | EP | disclosed |
| US-5968927-A | AZEPINO-INDOLE COMPOUNDS; TREATMENT OF INFLAMMATORY, AUTOIMMUNE AND NEURODEGENERATIVE DISEASES, PREVENTION OF ISCHEMIC INJURY | IDUN PHARMACEUTICALS, INC. (US) | 1999-10-19 | — | — | US | disclosed |
| WO-1999049864-A1 | INDOLE-2,3-DIONE-3-OXIME DERIVATIVES FOR THERAPEUTIC USE | NEUROSEARCH A/S (DK) | 1999-10-07 | — | — | WO | disclosed |
| US-5952368-A | AN INHIBITORS OF PROSTAGLANDIN G/H SYNTHASE, ANTIINFLAMMATORY AND ANALGESIC AGENTS | SYNTEX (U.S.A.) INC. (US) | 1999-09-14 | — | — | US | disclosed |
| CN-1225629-A | Novel pyrrole derivatives | HOFFMANN LA ROCHE (CH) | 1999-08-11 | — | — | CN | disclosed |
| US-5929084-A | Huperzine A derivatives, their preparation and their use | SHANGAHI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES (CN) | 1999-07-27 | — | — | US | disclosed |
| EP-0929311-A1 | INHIBITION OF APOPTOSIS USING INTERLEUKIN-1 beta-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS | Idun Pharmaceuticals, Inc. (US) | 1999-07-21 | — | — | EP | disclosed |
| US-5917053-A | INHIBITING GABA RELEASE FROM NEURONS | NEUROSEARCH A/S (DK) | 1999-06-29 | — | — | US | disclosed |
| EP-0906279-A1 | NOVEL PYRROLE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1999-04-07 | — | — | EP | disclosed |
| CN-1207100-A | Novel indole-2,3-done-3-oxime derivatives | NEUROSEARCH AS (DK) | 1999-02-03 | — | — | CN | disclosed |
| CN-1207101-A | Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes | IDUM PHARMACEUTICALS INC (US) | 1999-02-03 | — | — | CN | disclosed |
| US-5849510-A | Factor Xa inhibitors | SELECTIDE CORPORATION (US) | 1998-12-15 | — | — | US | disclosed |
| US-5843945-A | AMPA antagonists and a method of treatment | NEUROSEARCH A/S (DK) | 1998-12-01 | — | — | US | disclosed |
| EP-0869958-A1 | NOVEL INDOLE-2,3-DIONE-3-OXIME DERIVATIVES | NEUROSEARCH A/S (DK) | 1998-10-14 | — | — | EP | disclosed |
| US-5801174-A | CEREBROVASCULAR DISORDERS | NEUROSEARCH A/S (DK) | 1998-09-01 | — | — | US | disclosed |
| WO-1998013007-A9 | METHODS AND COMPOSITIONS FOR LIPIDIZATION OF HYDROPHILIC MOLECULES | — | 1998-08-13 | — | — | WO | disclosed |
| US-5780493-A | TREATING BRAIN DISORDERS | NEUROSEARCH A/S (DK) | 1998-07-14 | — | — | US | disclosed |
| CN-1183773-A | Alpha-substituted pyrimidine-thioalkyl and alkylether compounds | UPJOHN CO (US) | 1998-06-03 | — | — | CN | disclosed |
| US-5739149-A | TREATING ASTHMA | ZENECA LIMITED (GB) | 1998-04-14 | — | — | US | disclosed |
| WO-1998014447-A1 | NOVEL INDOLE-2,3-DIONE-3-OXIME DERIVATIVES | NEUROSEARCH A/S (DK) | 1998-04-09 | — | — | WO | disclosed |
| WO-1998013007-A2 | METHODS AND COMPOSITIONS FOR LIPIDIZATION OF HYDROPHILIC MOLECULES | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 1998-04-02 | — | — | WO | disclosed |
| WO-1998010778-A1 | INHIBITION OF APOPTOSIS USING INTERLEUKIN-1β-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS | IDUN PHARMACEUTICALS, INC. (US) | 1998-03-19 | — | — | WO | disclosed |
| EP-0824524-A1 | ALPHA-SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETHER COMPOUNDS AS INHIBITORS OF VIRAL REVERSE TRANSCRIPTASE | PHARMACIA & UPJOHN COMPANY (US) | 1998-02-25 | — | — | EP | disclosed |
| EP-0698025-B1 | AMPA ANTAGONISTS AND A METHOD OF TREATMENT THEREWITH | NEUROSEARCH AS (DK) | 1997-12-17 | — | — | EP | disclosed |
| WO-1997046524-A1 | NOVEL PYRROLE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1997-12-11 | — | — | WO | disclosed |
| US-5663154-A | VIRICIDES, HIV, HEPATITIS | GLAXO WELLCOME INC. (US) | 1997-09-02 | — | — | US | disclosed |
| EP-0781284-A1 | INDOLE-2,3-DIONE-3-OXIME DERIVATIVES, THEIR PREPARATION AND USE | NEUROSEARCH A/S (DK) | 1997-07-02 | — | — | EP | disclosed |
| US-5635509-A | ASTHMA; BRONCHODILATOR AGENTS; VASODILATION MICROVASCULAR PERMEABILITY; MAST CELLS | ZENECA LIMITED (GB) | 1997-06-03 | — | — | US | disclosed |
| EP-0758341-A1 | FACTOR Xa INHIBITORS | SELECTIDE CORPORATION (US) | 1997-02-19 | — | — | EP | disclosed |
| WO-1996035678-A1 | ALPHA-SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETHER COMPOUNDS AS INHIBITORS OF VIRAL REVERSE TRANSCRIPTASE | PHARMACIA & UPJOHN COMPANY (US) | 1996-11-14 | — | — | WO | disclosed |
| US-5559249-A | 7'-amino-naphthazarin antibiotic derivatives | GRUPPO LEPETIT SPA (IT) | 1996-09-24 | — | — | US | disclosed |
| US-5554626-A | TREATMENT OF PARKINSON*S DISEASE, DRUG ABUSE/DEPENDENCE; COANIE/AMPHETAMINE ADDICTION | NEUROSEARCH A/S (DK) | 1996-09-10 | — | — | US | disclosed |
| US-5530133-A | VAGINAL INFECTIONS | GRUPPO LEPETIT SPA (IT) | 1996-06-25 | — | — | US | disclosed |
| EP-0641346-B1 | 7'-AMINO-NAPHTHAZARIN ANTIBIOTIC DERIVATIVES | LEPETIT SPA (IT) | 1996-05-29 | — | — | EP | disclosed |
| WO-1996008494-A1 | INDOLE-2,3-DIONE-3-OXIME DERIVATIVES, THEIR PREPARATION AND USE | NEUROSEARCH A/S (DK) | 1996-03-21 | — | — | WO | disclosed |
| WO-1996008495-A1 | FUSED INDOLE AND QUINOXALINE DERIVATIVES, THEIR PREPARATION AND USE | NEUROSEARCH A/S (DK) | 1996-03-21 | — | — | WO | disclosed |
| EP-0698025-A1 | AMPA ANTAGONISTS AND A METHOD OF TREATMENT THEREWITH | NEUROSEARCH A/S (DK) | 1996-02-28 | — | — | EP | disclosed |
| EP-0445731-B1 | Azabicyclo and azacyclo oxime and amine cholinergic agents and pharmaceutically acceptable salts thereof | WARNER LAMBERT CO (US) | 1996-01-10 | — | — | EP | disclosed |
| EP-0680962-A2 | Heterocyclic compounds | ZENECA LIMITED (GB) | 1995-11-08 | — | — | EP | disclosed |
| WO-1995029189-A1 | FACTOR Xa INHIBITORS | SELECTIDE CORPORATION (US) | 1995-11-02 | — | — | WO | disclosed |
| US-5444070-A | TREATING A DISEASE OR DISORDER WHICH IS RESPONSIVE TO THE INHIBITION OF DOPAMINE REUPTAKE BY ADMINISTERING A TROPANE DERIVATIVE | NEUROSEARCH A/S (DK) | 1995-08-22 | — | — | US | disclosed |
| EP-0641346-A1 | 7'-AMINO-NAPHTHAZARIN ANTIBIOTIC DERIVATIVES. | LEPETIT SPA (IT) | 1995-03-08 | — | — | EP | disclosed |
| US-5384319-A | Interleukin inhibitors; analgesics | CIBA-GEIGY CORPORATION (US) | 1995-01-24 | — | — | US | disclosed |
| EP-0394989-B1 | Peptide compounds, process for preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO (JP) | 1994-12-21 | — | — | EP | disclosed |
| US-5374636-A | Antidrug abuse, antidepressants, antiParkinson activity | NEUROSEARCH A/S (DK) | 1994-12-20 | — | — | US | disclosed |
| US-5369113-A | Certain 2,3-diphenyl-2-(1,2,4-oxadiazol-5-yl)tropanes useful as dopamide reuptake inhibitors | NEUROSEARCH A/S (DK) | 1994-11-29 | — | — | US | disclosed |
| WO-1994026747-A1 | AMPA ANTAGONISTS AND A METHOD OF TREATMENT THEREWITH | NEUROSEARCH A/S (DK) | 1994-11-24 | — | — | WO | disclosed |
| EP-0625158-A1 | THERAPEUTIC NUCLEOSIDES | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-11-23 | — | — | EP | disclosed |
| US-5332811-A | Antitumor intermediates | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 1994-07-26 | — | — | US | disclosed |
| EP-0604352-A2 | Aryl substituted heterocyclic compounds | NEUROSEARCH A/S (DK) | 1994-06-29 | — | — | EP | disclosed |
| EP-0604355-A2 | Akyl Substituted heterocyclic compounds | NEUROSEARCH A/S (DK) | 1994-06-29 | — | — | EP | disclosed |
| US-5306718-A | Analgesics, cognition activators | WARNER-LAMBERT COMPANY (US) | 1994-04-26 | — | — | US | disclosed |
| WO-1993014103-A1 | THERAPEUTIC NUCLEOSIDES | THE WELLCOME FOUNDATION LIMITED (GB) | 1993-07-22 | — | — | WO | disclosed |
| WO-1993012115-A1 | 7'-AMINO-NAPHTHAZARIN ANTIBIOTIC DERIVATIVES | GRUPPO LEPETIT S.P.A. (IT) | 1993-06-24 | — | — | WO | disclosed |
| US-5164372-A | Treatment of respiratory disorders, inflammation, dermatitis | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1992-11-17 | — | — | US | disclosed |
| EP-0337765-B1 | ACYLSULFONAMIDE DERIVATIVES OF ALPHA-CARBOCYCLYLTOLUIC ACIDS USED AS LEUKOTRIENE ANTAGONISTS | ICI AMERICAS INC. (US) | 1992-10-14 | — | — | EP | disclosed |
| US-5147867-A | Bactericides, (carba)penicillins | MERCK & CO., INC. (US) | 1992-09-15 | — | — | US | disclosed |
| US-5145990-A | Dehydropeptidase, carbapenicillin potentiation | MERCK & CO., INC. (US) | 1992-09-08 | — | — | US | disclosed |
| US-5138042-A | 6-deoxyanthracyclines | FARMITALIA CARLO ERBA S.P.A. (IT) | 1992-08-11 | — | — | US | disclosed |
| US-5095038-A | Antiinflammatory, antiallergens | ICI AMERICAS INC. (US) | 1992-03-10 | — | — | US | disclosed |
| US-5037970-A | 6-deoxyanthracyclines | FARMITALIA CARLO ERBA S.P.A. (IT) | 1991-08-06 | — | — | US | disclosed |
| US-5021439-A | Senile dementia and memory dysfunction | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1991-06-04 | — | — | US | disclosed |
| US-4980343-A | Inhibit colon and rectal tumors | BAYER AKTIENGESELLSCHAFT (DE) | 1990-12-25 | — | — | US | disclosed |
| US-4968717-A | SEROTONIN-AND CALCIUM-ANTAGONISTS | BASF AKTIENGESELLSCHAFT (DE) | 1990-11-06 | — | — | US | disclosed |
| US-4968790-A | HYPOGLYCEMIC AGENTS, PLANT GROWTH REGULATORS | AMERICAN CYANAMID COMPANY (US) | 1990-11-06 | — | — | US | disclosed |
| EP-0394989-A2 | Peptide compounds, process for preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-10-31 | — | — | EP | disclosed |
| US-4966855-A | SUBSTITUTED OXAZOLES OR THIAZOLES, FOR DETECTING HYDROGEN PEROXIDE | BOEHRINGER MANNHEIM GMBH (DE) | 1990-10-30 | — | — | US | disclosed |
| US-4962097-A | IN COMBINATION WITH A CARBAPENEM OR PENEM ANTIBIOTIC | MERCK & CO., INC. (US) | 1990-10-09 | — | — | US | disclosed |
| US-4940780-A | CARDIOVASCULAR DISORDERS, ASTHMA, ULCERS | BASF AKTIENGESELLSCHAFT (DE) | 1990-07-10 | — | — | US | disclosed |
| EP-0366469-A2 | Phosphorus containing enzyme inhibitors | MERCK & CO. INC. (US) | 1990-05-02 | — | — | EP | disclosed |
| EP-0365956-A2 | Carcinostatic agents | BAYER AG (DE) | 1990-05-02 | — | — | EP | disclosed |
| EP-0356223-A2 | HIV protease inhibitors useful for the treatment of aids | MERCK & CO. INC. (US) | 1990-02-28 | — | — | EP | disclosed |
| EP-0337714-A2 | HIV protease inhibitors useful for the treatment of aids | MERCK & CO. INC. (US) | 1989-10-18 | — | — | EP | disclosed |
| US-4755592-A | Statine-containing peptides useful in medicaments | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1988-07-05 | — | — | US | disclosed |
| US-4746649-A | Diamino acid derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1988-05-24 | — | — | US | disclosed |
| US-4668622-A | Phenolsulphonphthaleinyl-β-D-galactosides and diagnostic agents containing them | BOEHRINGER MANNHEIM GMBH (DE) | 1987-05-26 | — | — | US | disclosed |
| EP-0210545-A2 | Phosphorous containing enzyme inhibitors | MERCK & CO. INC. (US) | 1987-02-04 | — | — | EP | disclosed |
| EP-0209897-A2 | Peptide enzyme inhibitors | MERCK & CO. INC. (US) | 1987-01-28 | — | — | EP | disclosed |
| EP-0209848-A2 | Enzyme inhibitors | MERCK & CO. INC. (US) | 1987-01-28 | — | — | EP | disclosed |
| EP-0092352-B1 | 9-SUBSTITUTED CARBACYCLINS | THE UPJOHN COMPANY (US) | 1986-07-02 | — | — | EP | disclosed |
| US-4487960-A | 9-Substituted carbacyclin analogs | THE UPJOHN COMPANY (US) | 1984-12-11 | — | — | US | disclosed |
| US-4446322-A | Hydroxyl protected 3-(2-hydroxy-2-phenylethyl)-N-[(phenylamino)carbonyl]sydnone imine intermediates | AMERICAN HOME PRODUCTS CORPORATION (US) | 1984-05-01 | — | — | US | disclosed |
| EP-0092352-A1 | 9-Substituted carbacyclins | THE UPJOHN COMPANY (US) | 1983-10-26 | — | — | EP | disclosed |
| EP-0024924-B1 | SYDNONIMINES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | AMERICAN HOME PRODUCTS CORPORATION (US) | 1983-08-31 | — | — | EP | disclosed |
| WO-1982001187-A1 | CNS STIMULANTS | AMERICAN HOME PROD (US) | 1982-04-15 | — | — | WO | disclosed |
| EP-0049604-A1 | CNS stimulants | AMERICAN HOME PRODUCTS CORPORATION (US) | 1982-04-14 | — | — | EP | disclosed |
| US-4277609-A | Sydnone imines | AMERICAN HOME PRODUCTS CORPORATION (US) | 1981-07-07 | — | — | US | disclosed |
| EP-0024924-A2 | Sydnonimines, their preparation and pharmaceutical compositions containing them | AMERICAN HOME PRODUCTS CORPORATION (US) | 1981-03-11 | — | — | EP | disclosed |
| WO-1981000567-A1 | SYDNONE IMINES | AMERICAN HOME PROD (US) | 1981-03-05 | — | — | WO | disclosed |
| US-3979395-A | Process for the preparation of vincamine and other indole alkaloids | BUSKINE S.A. (CH) | 1976-09-07 | — | — | US | disclosed |
| US-3979395-A | Process for the preparation of vincamine and other indole alkaloids | BUSKINE S.A. (CH) | 1976-09-07 | — | — | US | disclosed |